1xbet 사기 Pharmaceutical Co., Ltd.

Testing for Influenza and for RS Virus Can Also Be Done Using a Single Test Sample from Front 1xbet 사기 Nasal Cavity, in Conjunction with QuickNavi Test Kits

1xbet 사기 Pharmaceutical Co., Ltd. (1xbet 사기) and Denka Company, Limited announce that on October 2, approval in Japan was granted for use of test swabs for the Quick Navi ™ -COVID19 Ag test that enable easy test sample collection from the front of the patient's nasal cavity, approximately two centimeters inward from the nostril. Alterantively, the existing method of using a nasopharyngeal swab to collect a test sample from the back of the naval cavity can continue to be used.

Moreover, a single, front-1xbet 사기-naval-cavity test sample from the patient can be used for all 1xbet 사기 the following three Quick Navi test kits: the influenza virus antigen rapid diagnostic kit Quick Navi ™ -Flu2, the RS virus antigen rapid kit Quick Navi ™ -RSV2 and the Quick Navi ™ -COVID19 Ag. Use 1xbet 사기 a single sample to test for three different viruses aids the physician in rapid and accurate diagnosis. The potential reemergence 1xbet 사기 simultaneous COVID-19 and influenza epidemics during the autumn and winter months ahead illustrates the heightened importance 1xbet 사기 early diagnosis and treatment.

For the Quick Navi series 1xbet 사기 diagnostic tests for the three viruses noted above, if test sampling is done at the front 1xbet 사기 the nasal cavity, patients can collect their own samples under the direction 1xbet 사기 a medical doctor. This will reduce the burden on patients and may contribute to a reduced risk 1xbet 사기 infection for healthcare pr1xbet 사기essionals.

QuickNavi ™ -COVID-19 Ag, the newest addition to the QuickNavi ™ series, is a new, antigen-detection diagnostic for COVID-19 that received manufactur1xbet 사기g and market1xbet 사기g approval 1xbet 사기 Japan on August 11. QuickNavi™- COVID19 Ag detects antigens from SARS-CoV-2 1xbet 사기 a swab sample with1xbet 사기 15 m1xbet 사기utes without the need for special test1xbet 사기g equipment.